ARCHIVES

FDA Advisors Uphold Broad Mandate To Limit Use Of ESA Products In Cancer Indications.

This article is from The Cancer Letter archive.

Vol. 33 No. 18 | May 11, 2007

Download PDF Visit The Full Archive

Related Articles

House Preserves Funds For Space Station; Cancer Societies Reiterate Support For $170 Million Increase For NCI

August 7, 1992

Trading In Stock Of U.S. Bioscience Halted, Newsletter Report Cited

October 9, 1992

NCCN, ACS Offer Publication For Patients About Nausea.

June 22, 2001

Foundation Gives Duke $2M For Brain Tumor Research.

March 23, 2001

DRCCA Board Oks Noncompetitive Contract Concepts

November 11, 1983

Rall Says NTP Must Have New Positions To Spend Extra $23 Million On Testing More Chemicals

September 7, 1979